0,950  0,001  NOS2 expression inhibitor
0,940  0,002  Monophenol monooxygenase inhibitor
0,937  0,003  Lipoxygenase inhibitor
0,920  0,002  AR expression inhibitor
0,915  0,003  CYP2C19 substrate
0,910  0,004  15-Lipoxygenase inhibitor
0,902  0,004  Aryl hydrocarbon receptor agonist
0,885  0,003  Radioprotector
0,881  0,002  CTGF expression inhibitor
0,880  0,004  CYP1A2 inhibitor
0,868  0,001  Melanin inhibitor
0,868  0,004  12-Lipoxygenase inhibitor
0,860  0,004  Chemoprotective
0,864  0,009  Apoptosis agonist
0,853  0,003  Skin whitener
0,846  0,003  UGT1A9 substrate
0,850  0,010  Transcription factor NF kappa B inhibitor
0,841  0,004  Antioxidant
0,836  0,002  UGT1A3 substrate
0,804  0,005  Chemopreventive
0,789  0,003  UGT1A1 substrate
0,796  0,012  Caspase 9 stimulant
0,783  0,007  Antihypercholesterolemic
0,770  0,005  Aldehyde oxidase inhibitor
0,780  0,018  Antiinflammatory
0,756  0,005  Caspase 3 stimulant
0,755  0,004  Free radical scavenger
0,751  0,009  Carcinogenic
0,765  0,023  Alpha-glucosidase inhibitor
0,742  0,003  NOS3 expression enhancer
0,753  0,014  Antineoplastic (breast cancer)
0,741  0,003  Antihypotensive
0,738  0,004  Hypoxia-inducible factor 1 alpha inhibitor
0,747  0,013  Antineoplastic (lung cancer)
0,736  0,005  Antiosteoporotic
0,741  0,010  CYP2C9 substrate
0,729  0,004  CYP2C19 inhibitor
0,729  0,007  Cytostatic
0,726  0,006  Bone diseases treatment
0,713  0,004  MAO A inhibitor
0,709  0,004  MAO inhibitor
0,703  0,005  Antineoplastic (glioma)
0,697  0,005  Antimutagenic
0,694  0,008  CYP1A2 substrate
0,682  0,008  CYP2D6 substrate
0,681  0,007  Proliferative diseases treatment
0,654  0,005  UDP-glucuronosyltransferase substrate
0,645  0,004  Breast cancer-resistant protein inhibitor
0,645  0,008  NOS3 expression inhibitor
0,642  0,008  CYP2C9 inhibitor
0,642  0,009  Antineoplastic (melanoma)
0,638  0,008  Nitric oxide antagonist
0,635  0,007  UGT1A6 substrate
0,631  0,004  Sulfotransferase substrate
0,639  0,014  Prostate cancer treatment
0,641  0,019  Antineoplastic (colorectal cancer)
0,639  0,019  TNF expression inhibitor
0,628  0,008  Cardioprotectant
0,629  0,010  Cardiovascular analeptic
0,637  0,019  Antineoplastic (colon cancer)
0,621  0,008  Antineoplastic (brain cancer)
0,609  0,003  Estrogen receptor alpha antagonist
0,609  0,005  Antihypoxic
0,622  0,021  Antileukemic
0,592  0,014  Mutagenic
0,581  0,004  Amylase inhibitor
0,596  0,020  Antibacterial
0,574  0,005  Genotoxic
0,569  0,004  Lipid peroxidase inhibitor
0,582  0,019  Respiratory analeptic
0,589  0,030  CYP3A4 substrate
0,556  0,005  MAO B inhibitor
0,562  0,014  Histamine release inhibitor
0,554  0,007  Antihypertriglyceridemic
0,542  0,004  Protein-tyrosine phosphatase inhibitor
0,544  0,009  Antineoplastic (osteosarcoma)
0,551  0,017  Antineoplastic (cervical cancer)
0,532  0,004  Protein-tyrosine phosphatase 1B inhibitor
0,528  0,003  Beta glucuronidase inhibitor
0,545  0,021  Antineoplastic (ovarian cancer)
0,537  0,019  Spasmolytic
0,520  0,012  Amyloid beta aggregation inhibitor
0,515  0,011  Vascular (periferal) disease treatment
0,515  0,012  Antineoplastic (glioblastoma multiforme)
0,519  0,018  Apoptosis antagonist
0,495  0,016  Hypoglycemic
0,474  0,004  Alkaline phosphatase inhibitor
0,471  0,002  Papain-like protease (SARS coronavirus) inhibitor
0,477  0,008  Carcinogenic, group 3
0,487  0,019  Antineoplastic (non-small cell lung cancer)
0,487  0,023  Antineoplastic (pancreatic cancer)
0,487  0,023  Sensitization
0,469  0,009  Hepatoprotectant
0,474  0,017  Antiparasitic
0,505  0,049  Cyclophilin D inhibitor
0,505  0,049  Antidiabetic
0,458  0,008  Bone formation stimulant
0,479  0,031  Streptokinase A inhibitor
0,466  0,019  Antiamyloidogenic
0,450  0,004  Heat shock protein 90 antagonist
0,450  0,005  5-Lipoxygenase inhibitor
0,460  0,015  Vasodilator
0,464  0,021  Antiprotozoal (Leishmania)
0,445  0,002  Fatty acid synthase inhibitor
0,461  0,022  Antineoplastic (multiple myeloma)
0,457  0,019  Antiprotozoal (Trypanosoma)
0,463  0,028  Hepatic disorders treatment
0,445  0,015  Antineoplastic (renal cancer)
0,452  0,023  ICAM1 expression inhibitor
0,429  0,004  Xanthine oxidase inhibitor
0,435  0,013  Antihelmintic
0,426  0,017  Myocardial infarction treatment
0,411  0,004  Histidine decarboxylase inhibitor
0,419  0,013  UGT1A4 substrate
0,451  0,055  Antiparkinsonian
0,404  0,008  UGT2B15 substrate
0,437  0,043  Ulceration
0,441  0,049  Immunosuppressant
0,401  0,010  Topoisomerase II inhibitor
0,415  0,024  Superoxide dismutase inhibitor
0,387  0,005  Antihemorrhagic
0,397  0,018  RNA-directed DNA polymerase inhibitor
0,418  0,040  Antifungal
0,382  0,005  NADPH oxidase inhibitor
0,389  0,017  P-glycoprotein inhibitor
0,375  0,004  Estrogen receptor beta antagonist
0,439  0,074  Alzheimer's disease treatment
0,385  0,022  Antiulcerative
0,384  0,024  Pyruvate kinase inhibitor
0,395  0,039  Analeptic
0,387  0,031  Huntington's disease treatment
0,381  0,027  Antineoplastic (liver cancer)
0,354  0,004  Gastritis treatment
0,362  0,014  Mcl-1 antagonist
0,362  0,017  Platelet adhesion inhibitor
0,380  0,035  UGT2B4 substrate
0,380  0,039  Cytotoxic
0,348  0,008  Antineoplastic (bone cancer)
0,345  0,005  Antibacterial (Helicobacter pylori)
0,346  0,009  Neurotrophic factor enhancer
0,341  0,005  Estrogen antagonist
0,379  0,044  Lipoprotein disorders treatment
0,378  0,043  Vasodilator, coronary
0,342  0,009  Heat shock protein 90 alpha antagonist
0,348  0,021  Dual specificity phosphatase inhibitor
0,327  0,002  DOPA decarboxylase inhibitor
0,326  0,005  Aromatase inhibitor
0,364  0,045  CYP3A4 inhibitor
0,324  0,006  Dementia treatment
0,355  0,039  DNA damaging
0,325  0,009  Aldehyde dehydrogenase inhibitor
0,320  0,006  Vascular dementia treatment
0,331  0,018  VCAM1 expression inhibitor
0,315  0,002  SULT1E1 substrate
0,335  0,030  Antineoplastic enhancer
0,318  0,014  CYP2B6 inhibitor
0,313  0,010  Chelator
0,309  0,008  Neurotrophic factor
0,319  0,019  Antineoplastic (squamous cell carcinoma)
0,305  0,005  Estrogen agonist
0,340  0,043  Antipyretic
0,375  0,079  Antiprotozoal
0,313  0,020  Pneumotoxic
0,301  0,010  Carcinogenic, group 2B
0,297  0,008  Topoisomerase II alpha inhibitor
0,319  0,034  Peroxidase inhibitor
0,325  0,040  Angiogenesis stimulant
0,309  0,025  UGT2B7 substrate
0,341  0,059  Antimycobacterial
0,278  0,005  Postmenopausal disorders treatment
0,284  0,015  Acetylcholinesterase inhibitor
0,273  0,004  Lipase inhibitor
0,280  0,011  Cystathionine beta-synthase inhibitor
0,295  0,028  DNA methyltransferase I inhibitor
0,313  0,049  Tumour necrosis factor alpha release inhibitor
0,268  0,008  VEGF expression inhibitor
0,335  0,077  Angiogenesis inhibitor
0,269  0,014  Antifungal enhancer
0,262  0,014  SULT1A3 substrate
0,252  0,006  CF transmembrane conductance regulator agonist
0,262  0,019  Cyclooxygenase 1 inhibitor
0,246  0,006  ABCA1 expression enhancer
0,257  0,019  Antidiarrheal
0,299  0,063  Antidiabetic (type 2)
0,255  0,025  Tubulin antagonist
0,323  0,092  Prostaglandin dehydrogenase inhibitor
0,260  0,029  Insulin sensitizer
0,247  0,018  Cholesterol synthesis inhibitor
0,240  0,011  SULT1A1 substrate
0,257  0,029  Antiviral (West Nile virus)
0,291  0,064  Teratogen
0,299  0,079  Immunostimulant
0,249  0,031  Antineoplastic (carcinoma)
0,279  0,061  Antidiabetic symptomatic
0,221  0,004  Neuraminidase inhibitor
0,240  0,023  UGT2B9 substrate
0,257  0,044  DNA methylase inhibitor
0,252  0,042  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,211  0,005  Interleukin 5 antagonist
0,312  0,108  GABA C receptor rho-3 antagonist
0,206  0,004  Phosphodiesterase VI inhibitor
0,211  0,011  Photosensitizer
0,240  0,042  Male reproductive disfunction treatment
0,211  0,013  Coagulant
0,261  0,063  Antineoplastic (lymphoma)
0,265  0,068  Embryotoxic
0,260  0,064  Antiglaucomic
0,215  0,023  Topoisomerase I inhibitor
0,228  0,038  Antiviral (Herpes)
0,212  0,023  Arachidonic acid antagonist
0,224  0,037  Cholinergic
0,220  0,033  Phospholipase A2 inhibitor
0,224  0,038  Antineoplastic (gastric cancer)
0,219  0,034  Antiseptic
0,212  0,029  UGT2B10 substrate
0,194  0,012  Antineoplastic (uterine cancer)
0,187  0,005  Neuraminidase (influenza) inhibitor
0,218  0,037  Succinate dehydrogenase inhibitor
0,224  0,044  Amyloid beta precursor protein antagonist
0,247  0,069  Hypolipemic
0,293  0,115  GST A substrate
0,229  0,055  Abortion inducer
0,229  0,056  Antiviral (Influenza)
0,177  0,005  Xanthine dehydrogenase inhibitor
0,192  0,022  Antineoplastic antibiotic
0,195  0,027  Gout treatment
0,178  0,012  NAD(P)H dehydrogenase (quinone) inhibitor
0,187  0,026  Farnesoid X receptor antagonist
0,243  0,085  Antineoplastic (bladder cancer)
0,193  0,035  Antiprotozoal (Coccidial)
0,182  0,025  Expectorant
0,200  0,044  Antiviral (Influenza A)
0,205  0,050  LDLR expression enhancer
0,180  0,024  MAP kinase kinase 4 inhibitor
0,158  0,005  CDC25B inhibitor
0,212  0,062  Non-steroidal antiinflammatory agent
0,161  0,012  HIV-1 integrase (3'-Processing) inhibitor
0,157  0,011  Peroxisome proliferator-activated receptor gamma agonist
0,157  0,012  CDC25A inhibitor
0,210  0,066  Wound healing agent
0,166  0,022  TRPA1 agonist
0,214  0,073  Antialcoholic
0,177  0,036  DNA polymerase I inhibitor
0,238  0,098  Antituberculosic
0,144  0,005  Estrogen receptor alpha agonist
0,145  0,006  Ca(v)3.1 blocker
0,147  0,012  Ornithine decarboxylase inhibitor
0,163  0,030  Butyrylcholinesterase inhibitor
0,173  0,040  Skin irritative effect
0,144  0,011  Aldose reductase inhibitor
0,182  0,050  Cyclooxygenase inhibitor
0,168  0,036  Interleukin 4 antagonist
0,151  0,020  Alcohol dehydrogenase inhibitor
0,162  0,032  Interleukin 1b antagonist
0,208  0,080  Interleukin antagonist
0,136  0,008  Estrogen receptor beta agonist
0,150  0,024  Creatine kinase inhibitor
0,147  0,022  Carbonic anhydrase XIII inhibitor
0,167  0,043  Movement disorders treatment
0,214  0,090  Antineoplastic (lymphocytic leukemia)
0,144  0,021  Phosphodiesterase 4D inhibitor
0,148  0,029  AMP-activated protein kinase stimulant
0,133  0,014  HIV-1 integrase (Strand Transfer) inhibitor
0,164  0,046  M18 aspartyl aminopeptidase inhibitor
0,122  0,004  Transcription factor RelA inhibitor
0,142  0,025  Electron transport complex I inhibitor
0,174  0,058  Diuretic
0,138  0,022  Antiviral (Coronavirus)
0,138  0,022  Antiviral (SARS coronavirus)
0,129  0,014  Leukotriene synthesis inhibitor
0,243  0,130  Cholesterol antagonist
0,135  0,022  Thioredoxin inhibitor
0,144  0,037  Alcohol dehydrogenase substrate
0,151  0,046  Antihelmintic (Trematoda)
0,131  0,026  UGT2B11 substrate
0,117  0,018  Beta tubulin antagonist
0,132  0,034  Urease inhibitor
0,213  0,118  Transcription factor STAT3 inhibitor
0,156  0,064  Protein kinase stimulant
0,159  0,067  Interferon gamma antagonist
0,130  0,039  Multidrug resistance-associated protein 1 inhibitor
0,167  0,076  Phospholipase C inhibitor
0,134  0,043  Antiviral (Influenza B)
0,140  0,051  Vanilloid 1 agonist
0,133  0,044  Mucolytic
0,123  0,036  Uric acid excretion stimulant
0,115  0,028  Macrophage migration inhibitory factor inhibitor
0,110  0,023  Na+ K+ transporting ATPase inhibitor
0,236  0,152  Antiprotozoal (Plasmodium)
0,147  0,064  Antifungal (Cryptococcus)
0,166  0,084  Dual specificity phosphatase 3 inhibitor
0,093  0,011  Estradiol 17 beta-dehydrogenase inhibitor
0,140  0,060  Antiprotozoal (Trichomonas)
0,109  0,029  Telomerase inhibitor
0,095  0,016  Alpha tubulin antagonist
0,126  0,047  Aldehyde dehydrogenase substrate
0,223  0,145  GST M1-1 substrate
0,107  0,032  Antibiotic
0,093  0,019  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,098  0,026  SULT1A2 substrate
0,116  0,043  Anabolic
0,202  0,131  Tyrosine 3 hydroxylase inhibitor
0,084  0,014  Leukotriene B4 antagonist
0,103  0,034  Inducible nitric-oxide synthase inhibitor
0,118  0,050  UGT2B1 substrate
0,078  0,011  Cathepsin L2 inhibitor
0,074  0,009  Retinoid X receptor agonist
0,201  0,136  Transcription factor STAT inhibitor
0,097  0,032  Keratolytic
0,093  0,029  HIV-1 integrase inhibitor
0,144  0,084  Eye irritation, high
0,078  0,018  Sphingosine kinase inhibitor
0,123  0,064  Beta amyloid protein antagonist
0,064  0,005  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,154  0,095  Antipruritic, non-allergic
0,073  0,014  Glucose-6-phosphate translocase inhibitor
0,127  0,070  Toll-Like receptor 2 antagonist
0,084  0,028  Peroxisome proliferator-activated receptor gamma antagonist
0,112  0,056  HDL-cholesterol increasing
0,112  0,056  Mediator release inhibitor
0,058  0,004  Estrogen-related receptor beta antagonist
0,069  0,018  Dihydroorotate oxidase inhibitor
0,118  0,067  Proteasome inhibitor
0,056  0,005  Leukotriene B4 receptor 1 antagonist
0,211  0,164  Antithrombotic
0,119  0,072  Contraceptive female
0,083  0,038  Phosphodiesterase V inhibitor
0,072  0,029  Androgen agonist
0,208  0,165  Thioredoxin glutathione reductase inhibitor
0,081  0,039  Phosphodiesterase 5A inhibitor
0,156  0,114  Cardiodepressant
0,105  0,064  Glutathione S-transferase substrate
0,044  0,005  Leukotriene B4 receptor 2 antagonist
0,058  0,019  Cholesterol esterase inhibitor
0,063  0,024  Pregnane X receptor antagonist
0,257  0,219  5 Hydroxytryptamine release inhibitor
0,050  0,012  Retinoid X receptor antagonist
0,122  0,085  Interleukin 1 antagonist
0,051  0,014  Retinoid X alpha receptor agonist
0,175  0,138  Peptidyltransferase inhibitor
0,062  0,025  Peroxisome proliferator-activated receptor alpha agonist
0,118  0,082  Cyclooxygenase 2 inhibitor
0,087  0,052  Antiviral (Trachoma)
0,056  0,022  Factor III inhibitor
0,049  0,016  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,122  0,089  Histone deacetylase SIRT1 inhibitor
0,050  0,017  DNA gyrase subunit A inhibitor
0,152  0,121  Antirickettsial
0,196  0,165  Thyroid hormone antagonist
0,133  0,102  Ca2+-transporting ATPase inhibitor
0,086  0,055  Vanilloid agonist
0,115  0,084  Cyclooxygenase 3 inhibitor
0,072  0,041  Potassium channel large-conductance Ca-activated activator
0,132  0,101  Hexokinase inhibitor
0,094  0,064  Bile acid receptor antagonist
0,054  0,026  Potassium channel Kv1.3 blocker
0,086  0,059  Androgen antagonist
0,055  0,030  Vanilloid 2 antagonist
0,183  0,157  Antineoplastic (sarcoma)
0,051  0,026  Carbonic anhydrase VII inhibitor
0,044  0,020  Retinoic acid alpha receptor agonist
0,067  0,043  Leukotriene antagonist
0,084  0,060  Myeloperoxidase inhibitor
0,059  0,036  Postcoital contraceptive
0,097  0,076  Antiinfertility, female
0,083  0,061  D-Ala-D-Ala ligase inhibitor
0,081  0,060  Thioredoxin reductase inhibitor
0,038  0,018  Retinoid X alpha receptor antagonist
0,134  0,115  Carcinogenic, group 1
0,036  0,018  Peroxisome proliferator-activated receptor delta antagonist
0,170  0,152  Nitric-oxide synthase stimulant
0,124  0,106  Thrombolytic
0,035  0,019  Catechol O-methyltransferase inhibitor
0,049  0,036  CD45 antagonist
0,089  0,076  Carbonic anhydrase III inhibitor
0,060  0,047  Antimycoplasmal
0,038  0,026  5-Alpha-reductase inhibitor
0,085  0,075  Protein kinase C zeta inhibitor
0,125  0,115  GABA C receptor rho-2 antagonist
0,118  0,109  Antidote
0,027  0,018  Sodium/glucose cotransporter 2 inhibitor
0,123  0,117  Adenylate cyclase stimulant
0,064  0,059  Exportin-1 inhibitor
0,018  0,016  Inosine monophosphate dehydrogenase 1 inhibitor
0,172  0,170  Radiosensitizer

